[go: up one dir, main page]

CN101088553B - Effective Parts of Alkaloids and Their Applications - Google Patents

Effective Parts of Alkaloids and Their Applications Download PDF

Info

Publication number
CN101088553B
CN101088553B CN2006100277170A CN200610027717A CN101088553B CN 101088553 B CN101088553 B CN 101088553B CN 2006100277170 A CN2006100277170 A CN 2006100277170A CN 200610027717 A CN200610027717 A CN 200610027717A CN 101088553 B CN101088553 B CN 101088553B
Authority
CN
China
Prior art keywords
alkaloids
exchange resin
ethanol
extraction
cation exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006100277170A
Other languages
Chinese (zh)
Other versions
CN101088553A (en
Inventor
张彤
张亚中
陶建生
季光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai University of Traditional Chinese Medicine
Original Assignee
Shanghai University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai University of Traditional Chinese Medicine filed Critical Shanghai University of Traditional Chinese Medicine
Priority to CN2006100277170A priority Critical patent/CN101088553B/en
Publication of CN101088553A publication Critical patent/CN101088553A/en
Application granted granted Critical
Publication of CN101088553B publication Critical patent/CN101088553B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to extraction process and medicinal application of sessile stemona alkaloid. Sessile stemona alkaloid is extracted through the following steps: 1. extracting with alcohol solution or acid aqua; and 2. purifying with cation exchange resin. The sessile stemona alkaloid product has the sessile stemona alkaloid content over 50 %. The extracting process uses alcohol, no toxic organic solvent and reusable cation exchange resin, and has high safety and low cost. The medicine composition with the sessile stemona alkaloid may be used in treating skin diseases and diseasesof respiratory tract, and in preventing and controlling plant diseases and pests.

Description

百部生物碱有效部位及其应用 Effective parts of alkaloids and their application

技术领域technical field

本发明涉及一种中药有效部位及其药物制剂的应用,具体涉及一种百部生物碱有效部位及包含百部生物碱有效部位的药物制剂及其应用。 The present invention relates to an effective part of a traditional Chinese medicine and the application of the pharmaceutical preparation thereof, in particular to an effective part of the alkaloids of the plant and a pharmaceutical preparation containing the effective part of the alkaloids of the plant and an application thereof. the

技术背景 technical background

查阅国内外关于百部的文献报道,发现关于百部总生物碱的提取方法较少。林文翰{[1]林文翰,叶阳,徐任生.狭叶百部中新生物碱的结构研究.有机化学,1991,11:500-3;[2]林文翰,徐任生.钟琼芯百部生物碱的化学研究I.细花百部新生物碱.化学学报,1991,49:927-31.[3]林文翰,徐任生,钟琼芯.百部生物碱的化学研究II.细花百部中微量生物碱的结构研究.化学学报,1991,49:1034-37.}等分别在其上述文章中报道了几种提取方法。 Checking the domestic and foreign literature reports on Ceprea, it is found that there are few extraction methods for the total alkaloids of Ceprea. Lin Wenhan {[1] Lin Wenhan, Ye Yang, Xu Rensheng. A Study on the Structure of New Alkaloids in Centipeda Antatus. Organic Chemistry, 1991, 11: 500-3; [2] Lin Wenhan, Xu Rensheng. Zhong Qiongxin. Chemical research on the new alkaloids of Phyllostachys chinensis. Acta Chimica Sinica, 1991, 49: 927-31. [3] Lin Wenhan, Xu Rensheng, Zhong Qiongxin. Chemical research on the alkaloids of Phyllostachys chinensis II. Structural studies of bases. Acta Chemie Sinica, 1991, 49: 1034-37.} and others reported several extraction methods in their above articles. the

方法一:取600g生药根部经切片后用95%工业酒精冷渗漉一周,渗漉液减压浓缩,经3%HCI酸化,过滤,滤液用二氯乙烷洗两次,再用氨水碱化至pH11,氯仿萃取,减压浓缩,得粗总碱2.0g; Method 1: take 600g of crude drug roots, cut into slices, and cold percolate with 95% industrial alcohol for one week, concentrate the percolation solution under reduced pressure, acidify with 3% HCI, filter, wash the filtrate twice with dichloroethane, and alkalize with ammonia water to pH11, extracted with chloroform, and concentrated under reduced pressure to obtain 2.0 g of crude total alkali;

方法二:取2.5kg海南岛产细花百部根部,经磨粉后,于索氏提取器中用氯仿回流提取,提取液经浓缩后用4%稀盐酸酸化,过滤后滤液用氨水碱化,氯仿萃取,减压浓缩.得粗总碱8.2g; Method 2: Take 2.5kg of the roots of A. chinensis produced in Hainan Island, grind them into powder, and extract them with chloroform under reflux in a Soxhlet extractor. After concentration, the extract is acidified with 4% dilute hydrochloric acid. After filtration, the filtrate is alkalized with ammonia water. , extracted with chloroform, and concentrated under reduced pressure to obtain 8.2g of crude total alkali;

方法三:取2.5kg海南岛产细花百部根部,经磨粉,以95%工业酒精冷渗漉,渗漉液经减压浓缩成浸膏,然后用4%HCL溶解过滤,滤渡用浓氨水碱化至pH-10,氯仿萃取,减压浓缩得粗总碱1lg。 Method 3: Take 2.5kg of the roots of B. chinensis produced in Hainan Island, grind them into powder, and cold percolate with 95% industrial alcohol. The concentrated ammonia water was basified to pH-10, extracted with chloroform, and concentrated under reduced pressure to obtain 11 g of crude total alkali. the

Ge Lin等在其美国专利US2003229071里报道百部总生物碱的提取工艺为:百部粉碎,用95%乙醇回流提取2小时,倾出提取液10℃放置过夜,滤过,滤液减压回收至稠膏,用4%的盐酸酸化,5℃,3000转/分钟离心40分钟,上清夜用氨水碱化至pH9,然后用分别用二乙醚和氯仿萃取,合并有机相,减压回收,干燥得总生物碱的提取物。由上述报道可知,发现目前提取工艺中均大量采用氯仿等有机溶剂萃取的方法,提取量只有0.33%~0.44%,不利于规模化生产。 Ge Lin et al. reported in their U.S. patent US2003229071 that the extraction process of the total alkaloids of the plant was as follows: the plant was crushed, extracted with 95% ethanol under reflux for 2 hours, poured out the extract and placed at 10°C overnight, filtered, and the filtrate was recovered under reduced pressure to The thick paste was acidified with 4% hydrochloric acid, centrifuged at 5°C at 3000 rpm for 40 minutes, the supernatant was basified with ammonia water to pH9, then extracted with diethyl ether and chloroform respectively, the organic phases were combined, recovered under reduced pressure, and dried to obtain Extract of total alkaloids. It can be seen from the above reports that it is found that a large number of organic solvents such as chloroform are used in the current extraction process, and the extraction amount is only 0.33% to 0.44%, which is not conducive to large-scale production. the

发明内容Contents of the invention

本发明的目的在于提供一种高纯度、疗效佳的百部生物碱有效部位。 The purpose of the present invention is to provide a high-purity, effective part of the alkaloids of bacifera with good curative effect. the

本发明的另一目的在于提供百部生物碱有效部位的应用。 Another object of the present invention is to provide the application of the effective fractions of the alkaloids of Phetaceae. the

本发明的技术方案如下: Technical scheme of the present invention is as follows:

一种百部生物碱有效部位,是通过如下方法提取得到的,包括两步: A kind of effective part of alkaloids of basilica, which is extracted by the following method, including two steps:

(1)、采用乙醇或酸水提取:将百部药材粉碎成粗粉,并用70%-90%乙醇加热回流或渗漉提取或者用pH值为1-5的酸水提取; (1) Extraction with ethanol or acid water: grind the medicinal material of Herba Cinnamomi into a coarse powder, and use 70%-90% ethanol to reflux or extract by percolation or extract with acid water with a pH value of 1-5;

(2)、阳离子交换树脂纯化:将(1)步骤提取的上清液通过阳性交换树脂,洗脱除去水溶性杂质,以氨水和乙醇溶液洗脱,至碘化铋钾反应成阴性,停止洗脱,洗脱液减压回收至干,粉碎,得百部总生物碱提取物。所得百部生物碱有效部位的纯度在50%以上。 (2), cation exchange resin purification: pass the supernatant extracted in step (1) through a positive exchange resin, elute to remove water-soluble impurities, elute with ammonia water and ethanol solution, until bismuth potassium iodide reacts negatively, stop washing The eluate is recovered to dryness under reduced pressure, and pulverized to obtain the total alkaloid extract of the plant. The purity of the effective parts of the obtained basilica alkaloids is above 50%. the

在上述方法中,优选地,步骤(1)是采用90%乙醇提取,不浸泡,提取3次,每次1小时;步骤(2)的氨水和乙醇洗脱液体积比为:4∶1~1∶4。 In the above method, preferably, step (1) is extracted with 90% ethanol, without soaking, and extracted 3 times, each time for 1 hour; the volume ratio of ammonia water and ethanol eluent in step (2) is: 4: 1~ 1:4. the

所用阳离子交换树脂为强酸性或弱酸性阳离子交换树脂。阳离子交换树脂可以反复再生使用。 The cation exchange resin used is a strongly acidic or weakly acidic cation exchange resin. Cation exchange resins can be regenerated repeatedly. the

上述百部生物碱有效部位可用于制备治疗螨虫、脚癣、体癣、酒渣鼻、皮炎、湿疹、荨麻疹、体虱、头虱、滴虫性阴道炎等疾病的药物或化妆品,药物的剂型可以是软膏剂、凝胶剂、洗剂、栓剂药品。还可用于制备咳嗽、支气管炎、肺炎、肺结核等呼吸系统疾病的药物,药物剂型可以是片剂、软胶囊剂、微囊剂、颗粒剂、丸剂、散剂、缓释制剂、控释制剂、胃肠定位制剂、口服液体制剂、注射液、粉针等药剂学上所有可以接受的剂型。还可以用于制备治疗蛲虫病、蛔虫病等人体和动物寄生虫疾病的药物,并可应用于制备防治果树、蔬菜、花卉、玉米等多种植物病害虫害的药物。 The effective parts of the alkaloids above can be used to prepare medicines or cosmetics for treating diseases such as mites, athlete's foot, tinea corporis, rosacea, dermatitis, eczema, urticaria, body lice, head lice, trichomonas vaginitis, and the dosage form of medicines It can be ointment, gel, lotion, suppository medicine. It can also be used to prepare drugs for cough, bronchitis, pneumonia, tuberculosis and other respiratory diseases. Intestinal targeting preparations, oral liquid preparations, injections, powder injections and other pharmaceutically acceptable dosage forms. It can also be used to prepare medicines for treating human and animal parasitic diseases such as pinworms and ascariasis, and can be applied to prepare medicines for preventing and controlling various plant diseases and insect pests such as fruit trees, vegetables, flowers, and corns. the

本发明的优点:本专利采用了可规模化生产的乙醇/酸水提取-阳离子交换树脂纯化的技术制备对百部总生物碱进行富集,百部生物碱有效部位含量在50%以上。整个提取、分离过程除乙醇外,没有使用其他有毒有机溶剂。离子交换树脂可以重复使用,工业化生产安全,成本低、制备的百部生物碱有效部位纯度高。 The advantages of the present invention: the patent adopts the ethanol/acid water extraction-cation exchange resin purification technology that can be produced in a large scale to prepare and enrich the total alkaloids of the plant, and the content of the effective parts of the plant is more than 50%. The entire extraction and separation process does not use other toxic organic solvents except ethanol. The ion exchange resin can be used repeatedly, the industrialized production is safe, the cost is low, and the effective part of the prepared basil alkaloid has high purity. the

具体实施方式Detailed ways

实施例1 Example 1

百部药材2000g,粉碎,用pH为1的酸水溶液渗漉提取,取上清液通过HZ004型阳性交换树脂,树脂∶药材(1∶3),先以去离子水洗脱除去水溶性杂质,至无多糖反应,以氨水和乙醇2∶1配比的溶液洗脱,至碘化铋钾反应成阴性,停止洗脱,洗脱液减压回收至干,粉碎,得百部总生物碱提取物35g。 2000g of herbal medicines, pulverized, percolated and extracted with an aqueous acid solution with a pH of 1, and the supernatant was passed through a HZ004 type positive exchange resin, resin: medicinal materials (1:3), and firstly eluted with deionized water to remove water-soluble impurities. Until there is no polysaccharide reaction, elute with a solution of ammonia water and ethanol in a ratio of 2:1, until the reaction of bismuth potassium iodide becomes negative, stop the elution, and recover the eluate to dryness under reduced pressure, crush it, and obtain the total alkaloids of the plant. Material 35g. the

实施例2 Example 2

百部药材100kg,粉碎,90%乙醇渗漉提取。减压回收乙醇,得稠浸膏。以1%盐酸水浴加热溶解,用量以每克药材1毫升1%盐酸最佳,酸水液离心,取上清夜,通过JK008阳性交换树脂(树脂∶药材1∶4),先以去离子水洗脱除去水溶性杂质,至无多糖反应,以氨水和乙醇1∶1配比的溶液洗脱,至碘化铋钾反应成阴性,停止洗脱,洗脱液减压回收至干,粉碎,得百部总生物碱提取物1.5kg。 100kg of herbal medicines, crushed and extracted by percolation with 90% ethanol. Ethanol was recovered under reduced pressure to obtain a thick extract. Heat and dissolve with 1% hydrochloric acid in a water bath, the best dosage is 1 ml of 1% hydrochloric acid per gram of medicinal material, centrifuge the acid water, take the supernatant, pass it through JK008 positive exchange resin (resin: medicinal material 1:4), and wash with deionized water first Remove water-soluble impurities until there is no polysaccharide reaction, elute with a solution of ammonia water and ethanol in a ratio of 1:1, stop the elution until the reaction of potassium bismuth iodide becomes negative, and recover the eluent to dryness under reduced pressure, crush to obtain 1.5kg of total alkaloid extract of 100 stems. the

实施例3 Example 3

百部生物碱有效部位软膏剂 Baibu alkaloid active part ointment

百部生物碱1g,硬脂酸15g,羊毛脂2g,液体石蜡25ml,三乙醇胺2g,甘油5ml,蒸馏水50ml。 Alkaloids 1g, stearic acid 15g, lanolin 2g, liquid paraffin 25ml, triethanolamine 2g, glycerin 5ml, distilled water 50ml. the

取百部生物碱用少量液体石蜡研匀,备用。硬脂酸、羊毛脂和液体石蜡置容器内,水浴加热至熔化,继续加热至70~80℃;另取三乙醇胺、甘油和蒸馏水,加热至70~80℃,慢慢倒入硬脂酸等混合物,随加随向同一方向搅拌,并加入百部生物碱,至乳化凝结。外用,用于杀灭寄生于人体的蠕性螨虫。 Take the alkaloids of the basilica and grind it evenly with a small amount of liquid paraffin, and set it aside. Put stearic acid, lanolin and liquid paraffin in a container, heat in a water bath until melted, and continue to heat to 70-80°C; take another triethanolamine, glycerin and distilled water, heat to 70-80°C, slowly pour in stearic acid, etc. The mixture is stirred in the same direction as it is added, and alkaloids are added until emulsified and coagulated. For external use, it is used to kill Demodex mites parasitic on the human body. the

实施例4 Example 4

百部生物碱有效部位分散 The effective parts of the alkaloids are scattered

按百部生物碱有效部位50-120g,乳糖250g,甘露醇50g,交联聚乙烯吡咯烷酮(交联PVP)50g,95%乙醇适量,硬脂酸镁8g压制成片。可用于治疗咳嗽、支气管炎、肺炎、肺结核等呼吸系统疾病。 According to 50-120g of the active parts of the alkaloids, 250g of lactose, 50g of mannitol, 50g of cross-linked polyvinylpyrrolidone (cross-linked PVP), an appropriate amount of 95% ethanol, and 8g of magnesium stearate are compressed into tablets. It can be used to treat respiratory diseases such as cough, bronchitis, pneumonia and tuberculosis. the

实施例5 Example 5

百部生物碱有效部位气雾剂 Baibu alkaloid active parts aerosol

在百部生物碱有效部位100~200g中加入100ml二甲基亚砜,1000ml丙二醇振摇使溶解,加水至10,000,摇匀,滤过,得澄清药液,将上述药液在无菌室内定量分装于气雾剂容器中,将阀件固定于容器上然后在784.6kPa(8kg/cm2)压力下,向瓶内压入经微孔滤膜滤过的抛射剂F127.0g,即得溶液型气雾剂。共制得1000瓶。可作为安全、有效的杀虫剂。 Add 100ml of dimethyl sulfoxide to 100-200g of the active part of the alkaloids, shake 1000ml of propylene glycol to dissolve, add water to 10,000, shake well, filter to obtain a clarified drug solution, and quantify the above drug solution in a sterile room Dispensed in an aerosol container, fix the valve on the container and press 7.0g of propellant F 12 filtered through a microporous membrane into the bottle under a pressure of 784.6kPa (8kg/cm 2 ), namely A solution-type aerosol is obtained. A total of 1000 bottles were produced. Can be used as a safe and effective insecticide.

本发明是由发明人经过反复多次的试验获得的发明结果,包括对百部总生物碱的提取实验研究、有效部位的精制试验和药效学实验,内容如下: The present invention is the result of the invention obtained by the inventor through repeated tests, including the extraction experimental research on the total alkaloids of the plant, the refining test of the effective parts and the pharmacodynamic experiment. The contents are as follows:

1.百部总生物碱的提取实验 1. Extraction experiment of total alkaloids

1.1预试验 1.1 Pre-test

提取工艺研究发现,百部(浙江鄞州医药药材有限公司,蔓生百部,总生物碱含量1.32%)饮片直接用加热回流法提取,其总生物碱的提取率较低,分析原因可能是由于百部总碱在药材中含量较低,直接以饮片为原料提取时,生物碱很难从植物细胞中提出,导致提取率较低。而把百部饮片粉碎成粗粉后再提取。提取率有明显提高,用水作为溶剂时提取率为76.3%,用90%乙醇作为溶剂时提取率为91.6%。试验结果见表1。 The study of the extraction process found that the decoction pieces of Baibu (Zhejiang Yinzhou Pharmaceutical and Medicinal Materials Co., Ltd., vines, with a total alkaloid content of 1.32%) were directly extracted by heating and reflux, and the extraction rate of total alkaloids was low. The reason for the analysis may be due to The content of total alkaloids in medicinal materials is relatively low. When extracting directly from decoction pieces as raw materials, alkaloids are difficult to extract from plant cells, resulting in a low extraction rate. And the Baibu decoction pieces are crushed into coarse powder and then extracted. The extraction rate is obviously improved, the extraction rate is 76.3% when water is used as the solvent, and the extraction rate is 91.6% when 90% ethanol is used as the solvent. The test results are shown in Table 1. the

表1百部中生物碱提取的预试验结果 The preliminary test result of alkaloid extraction in table 1

药材量(g)Amount of medicinal materials (g)   粉碎程度degree of crushing   提取溶剂Extraction solvent   提取条件extraction conditions   提取率(%)Extraction rate (%) 5050   饮片Pieces   90%乙醇90% ethanol   12倍,2小时,2次12 times, 2 hours, 2 times   1616 5050   粗粉Semolina   水 water   12倍,2小时,2次12 times, 2 hours, 2 times   7676 5050   粗粉Semolina   90%乙醇90% ethanol   12倍,2小时,2次12 times, 2 hours, 2 times   9292

百部的提取工艺确定为:百部药材粉碎成粗粉,用乙醇提取,并通过正交试验进一步优化乙醇的提取工艺条件。 The extraction process of Baibu was determined as follows: the medicinal materials of Baibu were crushed into coarse powder, extracted with ethanol, and the extraction process conditions of ethanol were further optimized through orthogonal experiments. the

1.2正交试验 1.2 Orthogonal test

1.2.1因素水平表 1.2.1 Factor level table

根据预试验,固定提取溶剂为8倍量,对乙醇浓度(A)、浸泡时间(B)、提取时间(C)、提取次数(D)四个影响因素,分别在三个水平进行正交优选,按L9(34)正交表进行实验,因素水平安排见表2。 According to the preliminary test, the fixed extraction solvent is 8 times the amount, and the four influencing factors of ethanol concentration (A), soaking time (B), extraction time (C), and extraction times (D) are respectively optimized at three levels. , according to the L 9 (3 4 ) orthogonal table to carry out the experiment, and the arrangement of factor levels is shown in Table 2.

表2百部醇提正交实验因素水平表 Table 2 Alcohol Extraction Orthogonal Experiment Factor Level Table

  水平 level   醇浓度(%)/AAlcohol concentration (%)/A   浸泡时间(h)/BSoaking time (h)/B   提取时间(h)/CExtraction time (h)/C   提取次数/DExtraction times/D   1 1   9090   00   1 1   1 1   2 2   7070   1 1   2 2   2 2   33   5050   2 2   33   33

1.2.2正交试验及结果 1.2.2 Orthogonal test and results

分别称取百部(浙江鄞州医药药材有限公司,蔓生百部,总生物碱含量1.32%)粗粉50克27份(平行3份),按正交试验表5选择的条件进行提取,合并提取液,滤过,精密移取滤液适量,蒸干,用甲醇定容成10ml。精密吸取样品液100μl,置分液漏斗中,加蒸馏水5.0ml,加0.1%溴甲酚绿(pH5.0)的缓冲液2.0ml,氯仿10.0ml,振摇2分 钟,静置1小时,精密移取氯仿溶液5.0ml,精密加入含0.01mol/l氢氧化钾的无水乙醇液1ml,摇匀,置比色池中,随行空白,用分光光度计于620nm处测定吸光度,并计算样品中总生物碱的含量,试验结果见表3。 Take by weighing 27 parts of 50 grams (parallel 3 parts) of Ceprea (Zhejiang Yinzhou Pharmaceutical and Medicinal Materials Co., Ltd., vines, total alkaloid content 1.32%) coarse powder respectively, extract according to the conditions selected in Orthogonal Test Table 5, and combine the extraction liquid, filtered, and accurately pipette an appropriate amount of filtrate, evaporated to dryness, and dilute to 10ml with methanol. Precisely draw 100 μl of sample solution, put it in a separatory funnel, add 5.0ml of distilled water, add 2.0ml of buffer solution of 0.1% bromocresol green (pH5.0), 10.0ml of chloroform, shake for 2 minutes, and let it stand for 1 hour. Precisely pipette 5.0ml of chloroform solution, accurately add 1ml of absolute ethanol solution containing 0.01mol/l potassium hydroxide, shake well, put it in a colorimetric cell, and accompany it with a blank, measure the absorbance at 620nm with a spectrophotometer, and calculate the sample The content of total alkaloids in the test results are shown in Table 3. the

表3百部醇提正交试验结果表 Table 3 Alcohol Extraction Orthogonal Test Result Table

Figure G06127717020060630D000051
Figure G06127717020060630D000051

1.2.3正交试验结果的方差分析 1.2.3 Analysis of variance of orthogonal test results

正交试验结果的方差分析结果见表4。 The results of the variance analysis of the orthogonal test results are shown in Table 4. the

表4正交试验结果的方差分析结果 The results of analysis of variance of table 4 orthogonal test results

  方差来源source of variance   离差平方和sum of squared deviations   自由度degrees of freedom   方差Variance   F值F value   显著性Significance   AA   3732.433732.43   2 2   1866.221866.22   3.593.59   P<0.05P<0.05   BB   3558.663558.66   2 2   1779.331779.33   3.423.42   P>0.05P>0.05   CC   32906.9332906.93   2 2   16453.4716453.47   31.6131.61   P<0.01P<0.01   DD   38287.6038287.60   2 2   19143.8019143.80   36.7836.78   P<0.01P<0.01   误差EError E   9368.869368.86   1818   520.49520.49

F0.05(2,18)=3.55    F0.01(2,18)=6.01 F 0.05(2, 18) = 3.55 F 0.01(2, 18) = 6.01

直观分析,最佳工艺为A1B3C1D3,即90%乙醇,浸泡2小时,提取3次,每次1小 时,其中A(醇浓度)、C(提取时间)和D(提取次数)因素对提取率有显著性影响。因素B(浸泡时间)对提取率无显著性影响,可根据需要选择不同的水平。为了节省时间和成本,选择的最佳工艺为90%乙醇,不浸泡,提取3次,每次1小时。 Intuitive analysis, the best process is A 1 B 3 C 1 D 3 , that is, 90% ethanol, soaking for 2 hours, extracting 3 times, 1 hour each time, where A (alcohol concentration), C (extraction time) and D (extraction time) Times) factor has a significant impact on the extraction rate. Factor B (soaking time) has no significant impact on the extraction rate, and different levels can be selected according to needs. In order to save time and cost, the best process to choose is 90% ethanol, no soaking, extraction 3 times, 1 hour each time.

1.2.4正交试验结果的验证试验 1.2.4 Verification test of orthogonal test results

为进一步考察上述优选工艺的稳定性,按所得最佳条件,进行验证试验,平行提取3份百部药材(浙江鄞州医药药材有限公司),每份600g,提取物测定百部总碱的含量,结果见表5。 In order to further investigate the stability of the above-mentioned preferred process, according to the best conditions obtained, a verification test is carried out, and 3 parts of Herba Cinnamomi (Zhejiang Yinzhou Pharmaceutical and Medicinal Materials Co., Ltd.) are extracted in parallel, and each part of 600g is used to determine the content of total alkaloids of Cinnamomum japonicus. The results are shown in Table 5. the

表5正交试验结果的验证试验结果表 Table 5 Verification test result table of orthogonal test results

2.百部总生物碱有效部位的精制试验 2. Refining test of effective fractions of total alkaloids

根据试验结果,百部醇提液减压干燥后,得膏率为32%,不利于制剂的制备。在保证百部总碱转移率的前提下,为了降低得膏率,通过离子交换树脂法对百部总碱进行精制。 According to the test results, after drying under reduced pressure for the ethanol extract of Papaya, the yield of ointment is 32%, which is unfavorable for the preparation of the preparation. On the premise of ensuring the transfer rate of total alkaloids of bacuroni, in order to reduce the yield of ointment, the total alkaloids of baicalensis is refined by ion exchange resin method. the

2.1离子交换树脂型号及最大吸附量的考察 2.1 Investigation of ion exchange resin type and maximum adsorption capacity

方法:称取百部粗粉1kg,按正交试验优选的方法提取,提取液减压回收溶剂至稠浸膏状,用1%盐酸约1000ml充分溶解,酸水液离心,取上清液,分别通过不同型号的强酸性阳离子交换树脂,至流出液用碘化铋钾反应成阳性,停止上样,用去离子水洗脱,至Molish反应呈阴性(无多糖),停止洗脱,分别测定上样液、流出液和水洗液中百部总生物碱的量,按下式计算单位树脂的最大吸附量: Method: Weigh 1kg of the bacurbita coarse powder, extract according to the optimal method of the orthogonal test, extract the solution under reduced pressure and recover the solvent to a thick extract, fully dissolve it with about 1000ml of 1% hydrochloric acid, centrifuge the acid-water solution, and take the supernatant, Pass through different types of strongly acidic cation exchange resins until the effluent reacts positive with bismuth potassium iodide, stop loading the sample, and elute with deionized water until the Molish reaction is negative (no polysaccharide), stop elution, and measure For the amount of total alkaloids in the sample solution, effluent and washing solution, the maximum adsorption capacity per unit of resin is calculated according to the following formula:

最大吸附量=(m上样-m流出-m水洗)/m树脂 Maximum adsorption capacity = (m loading - m outflow - m washing ) / m resin

树脂:华东理工大学华震科技贸易公司生产的HZ004、HD008、JK008、HZ0016型4种阳离子离子交换树脂,三菱化学株式会社生产的SK1B阳离子交换树脂。 Resin: 4 types of cation ion exchange resins, HZ004, HD008, JK008, and HZ0016 produced by Huazhen Technology Trading Company of East China University of Science and Technology, and SK 1 B cation exchange resin produced by Mitsubishi Chemical Corporation.

结果:分别称取上述各树脂适量(按干树脂计为10g),装入R=1.8cm的层析柱中,按上述方法操作,计算最大吸附量,结果见表6。 Results: Weigh the appropriate amount of each of the above resins (10 g as dry resin), put them into a chromatographic column with R=1.8 cm, operate according to the above method, and calculate the maximum adsorption capacity. The results are shown in Table 6. the

表6单位树脂的最大吸附量考察结果表 Table 6 The maximum adsorption capacity investigation result table of unit resin

  树脂型号Resin model   含水量(%)Moisture content (%)   1g干树脂吸附的总生物碱量(g)The amount of total alkaloids adsorbed by 1g dry resin (g)   HZ004HZ004   68.568.5   0.31750.3175   HD008HD008   57.557.5   0.18320.1832   JK008JK008   57.157.1   0.30520.3052   HZ0016HZ0016   28.228.2   0.01960.0196   SK1BSK 1 B   46.046.0   0.10860.1086

结果:由表6可知,HZ004型强酸性阳离子交换树脂对百部总生物碱的吸附量最大,故初步选用HZ004型强酸性阳离子交换树脂。 Results: From Table 6, it can be known that the HZ004 strongly acidic cation exchange resin has the largest adsorption capacity for the total alkaloids of Phetaceae, so the HZ004 strongly acidic cation exchange resin was initially selected. the

2.2HZ004型强酸性阳离子交换树脂精制总生物碱的条件优化 2.2Optimization of conditions for refining total alkaloids with HZ004 type strongly acidic cation exchange resin

方法:取HZ004型强酸性阳离子交换树脂100g(按于树脂计约31g),装入层析柱中,上样600g药材的提取液,上样液的流速为1BV/h,上样结束后,用去离子水洗脱,至Molish反应呈阴性,停止洗脱,换成表1.9中所列的洗脱剂继续洗脱,至洗脱液碘化铋钾反应成阴性,测定洗脱液中总生物碱的含量,见表7。 Method: Take 100g of HZ004 type strongly acidic cation exchange resin (about 31g in terms of resin), put it into a chromatographic column, and load 600g of the extract of medicinal materials. The flow rate of the sample solution is 1BV/h. After the sample is loaded, Elute with deionized water until the Molish reaction is negative, stop the elution, change to the eluent listed in Table 1.9 and continue the elution until the eluent bismuth iodide potassium reaction becomes negative, measure the total The content of alkaloids is shown in Table 7. the

表7HZ-4型强酸性阳离子交换树脂精制总生物碱的条件优化 Table 7HZ-4 type strongly acidic cation exchange resin refining condition optimization of total alkaloids

  树脂   量Resin amount   上样液中   总碱量Total alkali content in sample solution   洗脱剂   (V氨水∶V乙醇)Eluent (V ammonia : V ethanol )   洗脱剂   用量Eluent dosage   得膏   率Anointing rate   干膏中总   碱含量Total alkali content in dry paste   干膏中   总碱量total alkali content in dry paste   洗脱率Elution rate   100g100g   6.77g6.77g   2∶12:1   280ml280ml   1.19%1.19%   51.5%51.5%   3.68g3.68g   54.32%54.32%   100g100g   6.77g6.77g   1∶11:1   240ml240ml   1.17%1.17%   58.6%58.6%   4.12g4.12g   60.79%60.79%   100g100g   6.77g6.77g   1∶21:2   380ml380ml   1.38%1.38%   42.2%42.2%   3.50g3.50g   51.63%51.63%

结果:选择V氨水∶V乙醇=1∶1为洗脱液洗脱。 Results: V ammonia water : V ethanol = 1:1 was selected as the eluent for elution.

2.3 HZ004型强酸性阳离子交换树脂精制总生物碱的验证实验 2.3 Verification experiment of refining total alkaloids with HZ004 strong acidic cation exchange resin

方法:取HZ004型强酸性阳离子交换树脂200g(按干树脂计62g),装入层析柱中,上样1200g药材的提取液,上样液的流速为1BV/h,上样结束后,用去离子水洗脱,至Molish反应成阴性,停止洗脱,换V氨水∶V乙醇=1∶1为洗脱液洗脱,至洗脱液碘化铋钾反应成阴性,测定洗脱液中总生物碱的含量,按下式计算相对比洗脱率。 Method: Take 200g of HZ004 type strongly acidic cation exchange resin (62g as dry resin), put it into a chromatographic column, and load 1200g of the extract of medicinal materials. The flow rate of the sample solution is 1BV/h. After the sample is loaded, use Elute with deionized water until the Molish reaction becomes negative, stop the elution, change V ammonia water: V ethanol = 1:1 as the eluent for elution, until the eluent bismuth potassium iodide reacts negative, measure the concentration of the eluent in the eluent For the content of total alkaloids, the relative elution rate was calculated according to the following formula.

相对比洗脱率(%)=(m洗脱/m上样)×100%,结果见表8。 Relative relative elution rate (%)=(m elution /m loading )×100%, the results are shown in Table 8.

表8HZ004型强酸性阳离子交换树脂精制总生物碱的条件验证 Table 8HZ004 type strong acidic cation exchange resin refining conditions verification of total alkaloids

Figure G06127717020060630D000081
Figure G06127717020060630D000081

总结:百部药材醇提平均得膏率32%,干浸膏中总生物碱含量3.5%,总生物碱转移率85%。醇提再通过强酸性阳离子交换树脂精制后平均得膏率降为1.18%,浸膏中总生物碱含量55.8%,总生物碱转移率49.8%。说明通过强酸性阳离子交换树脂精制可保留大部分指标成分,而浸膏得率大大下降,减少了服用剂量,便于制剂成型。 Summary: The average alcohol extraction rate of Baibu medicinal materials is 32%, the total alkaloid content in the dry extract is 3.5%, and the total alkaloid transfer rate is 85%. After alcohol extraction and refining by strong acidic cation exchange resin, the average extract rate is reduced to 1.18%, the total alkaloid content in the extract is 55.8%, and the total alkaloid transfer rate is 49.8%. It shows that most of the index components can be retained by refining with strong acidic cation exchange resin, while the yield of extract is greatly reduced, the dosage is reduced, and the formulation is facilitated. the

2.4 HZ004型强酸性阳离子交换树脂使用次数和再生次数考察 2.4 Investigation on the usage times and regeneration times of HZ004 strong acidic cation exchange resin

当树脂使用一定时间和次数后,树脂就会受到污染导致吸附能力降低,此时必须经过再生处理后才能继续使用。 When the resin is used for a certain period of time and times, the resin will be polluted and the adsorption capacity will be reduced. At this time, it must be regenerated before it can be used again. the

树脂再生方法为:①1N盐酸洗脱:用1N盐酸洗脱,用量为树脂体积的2~3倍,水洗至pH为5。流速为每小时树脂体积的2~3倍。②5%氯化钠洗脱:用树脂体积的5倍量的5%氯化钠洗脱。流速为每小时2~3倍树脂体积。③1N氢氧化钠洗脱:用1N氢氧化钠洗脱,用量为树脂体积的2~3倍,水洗至pH为9。流速为每小时树脂体积的2~3倍。④1N盐酸洗脱:用1N盐酸洗脱,用量为树脂体积的2~3倍,水洗至pH为6。流速为每小时树脂体积的2~3倍。 The resin regeneration method is: ① 1N hydrochloric acid elution: elution with 1N hydrochloric acid, the dosage is 2 to 3 times the volume of the resin, and washed with water until the pH is 5. The flow rate is 2 to 3 times the resin volume per hour. ②5% sodium chloride elution: use 5% sodium chloride 5 times the volume of the resin for elution. The flow rate is 2 to 3 times the resin volume per hour. ③ Elution with 1N sodium hydroxide: elution with 1N sodium hydroxide, the dosage is 2 to 3 times the volume of the resin, and washed with water until the pH is 9. The flow rate is 2 to 3 times the resin volume per hour. ④ 1N hydrochloric acid elution: elution with 1N hydrochloric acid, the dosage is 2 to 3 times the volume of the resin, and washed with water until the pH is 6. The flow rate is 2 to 3 times the resin volume per hour. the

参考生产厂家说明书,HZ-4型强酸性阳离子交换树脂使用后,以蒸馏水冲柱pH<8,以2倍树脂体积1N浓度盐酸冲洗转换成H型,以蒸馏水冲柱pH>6可继续使用。一般认为,当树脂吸附量下降30%时,树脂应进行按照上述再生方法进行再生,考察的结果见表9。 Refer to the manufacturer's instructions, after using HZ-4 strong acidic cation exchange resin, rinse the column with distilled water at pH < 8, rinse with 1N hydrochloric acid twice the volume of the resin to convert to H type, rinse the column with distilled water at pH > 6 and continue to use it. It is generally believed that when the resin adsorption capacity drops by 30%, the resin should be regenerated according to the above-mentioned regeneration method. The results of the investigation are shown in Table 9. the

表9 HZ-4型强酸性阳离子交换树脂使用次数及再生次数考察情况 Table 9 Investigation of the usage times and regeneration times of HZ-4 type strongly acidic cation exchange resin

  使用次数 usage count   总生物碱的吸附量(mg/g干树脂)Adsorption capacity of total alkaloids (mg/g dry resin)   占初始百分比(%)Accounted for the initial percentage (%)   1 1   0.31750.3175   100100   55   0.30230.3023   95.295.2   1010   0.27150.2715   85.585.5   1414   0.22730.2273   71.671.6   1515   0.21080.2108   66.466.4   再生1次Regenerate 1 time   1 1   0.30260.3026   95.395.3   55   0.23880.2388   75.275.2   66   0.21840.2184   68.868.8

实验结果表明:HZ004型强酸性阳离子交换树脂使用15次后需要再生,再生后使用5次不可再用。 The experimental results show that: HZ004 strong acidic cation exchange resin needs to be regenerated after being used for 15 times, and it cannot be reused after being used for 5 times. the

2.5中试 2.5 pilot test

按确定的精制工艺进行四批中试放样,测定各步过程中总碱的含量,总转移率,结果见表10。 Carry out four batches of pilot scale setting out according to the refined refining process of determination, measure the content of total alkali in each step process, total transfer rate, the result is shown in Table 10. the

表10制备工艺中试试验结果 Table 10 Preparation process pilot test results

  批号batch number   050525050525   050526050526   050527050527   050408050408   品种 Variety   对叶百部To Ye Baibu   对叶百部To Ye Baibu   蔓生百部vines   蔓生百部vines   投料量(kg)Feeding amount (kg)   1515   1515   1515   225225   药材TA含量(%)TA content of medicinal materials (%)   1.581.58   1.581.58   0.810.81   0.790.79   药材TA总量(g)The total amount of medicinal material TA (g)   236.4236.4   236.4236.4   121.5121.5   1777.51777.5   浸膏量(g)Amount of extract (g)   260260   269269   130130   44004400   浸膏得率(%)Extract yield (%)   1.731.73   1.791.79   0.870.87   ??   浸膏中TA含量(%)TA content in extract (%)   50.250.2   50.850.8   42.442.4   ??   提取精制过程TA转移率(%)TA transfer rate in extraction and refining process (%)   55.2155.21   57.8157.81   45.3745.37   ??

结果表明,中试工艺条件稳定。 The results show that the pilot test process conditions are stable. the

3.百部总生物碱有效部位的药效学实验 3. Pharmacodynamic experiments on the effective parts of the total alkaloids of Baibu

3.1百部生物碱有效部位除螨试验 3.1 Anti-mite test on the effective parts of Baibu alkaloids

用改良的刮压法最大限度地取人体蠕形螨到载玻片,置显微镜下观察计数,每份标本含有运动活泼的蠕形螨20条以上,取螨虫成功后立即在载玻片上分别加入不同浓度的百部总生物碱溶液3滴,并使其涂布均匀,保证药液与虫体的充分接触。空白组、对照组分别滴加等量的液体石腊和2%甲硝唑水剂。滴加药液后稍等片刻,把玻片置于显微镜下观察,计算各组活螨数量和标出各虫所在位置(方便实验过程中的观察)。如果实验时室温低于25℃,则把标本置于温度为25~28℃,相对湿度70%~80%的温箱中保暖,每隔1~2h取出在显微镜下观察1次,记录螨虫的活动情况,直至玻片上所有螨虫死亡为止。螨虫死亡判断标准如下:①虫体收缩或透明者;②虫体破裂,外周有油滴样堆积物者;③在高倍镜下连续观察1min,虫体或虫足不活动者。结果见表11。 Use the improved scraping and pressure method to take human Demodex mites as much as possible onto the glass slides, and observe and count them under a microscope. Each sample contains more than 20 active and active Demodex mites. After the mites are successfully collected, add them to the glass slides immediately Add 3 drops of different concentrations of the total alkaloid solution of Phetopaceae, and spread it evenly to ensure full contact between the liquid medicine and the worm body. The same amount of liquid paraffin and 2% metronidazole aqueous solution were added dropwise to the blank group and the control group respectively. Wait for a while after dropping the medicinal solution, put the slides under a microscope to observe, calculate the number of live mites in each group and mark the location of each insect (to facilitate observation during the experiment). If the room temperature is lower than 25°C during the experiment, put the specimen in an incubator with a temperature of 25-28°C and a relative humidity of 70%-80% to keep warm, take it out every 1-2 hours and observe it under a microscope to record the number of mites activity until all mites on the slide are dead. The criteria for judging the death of mites are as follows: ① those with shrunken or transparent mites; The results are shown in Table 11. the

表11百部生物碱除螨试验 Table 11 Baibu alkaloid mite removal test

Figure G06127717020060630D000101
Figure G06127717020060630D000101

由表可知,百部生物碱在10mg/ml浓度时与甲硝唑无显著性差异,在20mg/ml浓度时优于甲硝唑,在5mg/ml浓度时弱于甲硝唑。 It can be seen from the table that there is no significant difference between the alkaloids of 10mg/ml and metronidazole at the concentration of 10mg/ml, better than metronidazole at the concentration of 20mg/ml, and weaker than metronidazole at the concentration of 5mg/ml. the

3.2百部生物碱有效部位镇咳祛痰作用的实验研究 3.2 Experimental study on the antitussive and expectorant effects of the effective parts of alkaloids

3.2.1氨水致咳嗽试验 3.2.1 Ammonia induced cough test

灌胃给予相应药液1次,给药后1h,将小鼠分别置于自制的引咳装置中(带盖的300ml广口瓶),使小鼠接受氨水(定量吸取50ul氨水于滤纸条上)刺激至预定时间,立即取出小鼠,观察1min内小鼠的咳嗽次数。咳嗽声音通过麦克风录音并放大,在电脑中用WaveCN1.90软件分析,若1min内出现3次以上典型咳嗽动作(腹肌收缩或缩胸, 同时张大嘴为一次咳嗽,有时可有咳声)者,算作“有咳嗽”,否则算作“无咳嗽”。按统计学“上下法/序贯法”求半数有数量(EDT50)的原理,改变每只小鼠接受刺激的时间(相邻两个时刻的对数之差在一次实验中是固定的为0.1),以观察咳嗽反应是“有咳嗽”或“无咳嗽”。当前一只小鼠出现咳嗽反应,则后一只就用低一级的时间给予氨气刺激;相反,若未出现咳嗽,则下一只就用高一级的时间给予氨气刺激;最后一只动物不试验,以前一只小鼠相反的反应计数。用加权法分别计算给药组和对照组半数致咳时间(EDT50)及相对值R。 Intragastric administration of the corresponding medicinal solution once, 1 hour after the administration, the mice were respectively placed in a self-made cough-inducing device (300ml wide-mouth bottle with a cover), so that the mice received ammonia water (quantitatively draw 50ul of ammonia water on a filter paper strip) (above) Stimulate for a predetermined time, take out the mouse immediately, and observe the number of coughs of the mouse within 1 min. The coughing sound is recorded and amplified by a microphone, and analyzed in the computer with WaveCN1.90 software. If there are more than 3 typical coughing movements (abdominal muscle contraction or chest shrinkage, and mouth opening at the same time, it is a cough, sometimes there may be a coughing sound) within 1 minute. , counted as "with cough", otherwise counted as "no cough". According to the principle of statistical "up and down method/sequential method" to find half of the number ( EDT50 ), change the time for each mouse to receive stimulation (the logarithmic difference between two adjacent moments is fixed in an experiment as 0.1) to observe whether the cough response is "with cough" or "without cough". If the previous mouse had a cough reaction, the next mouse would be stimulated with ammonia gas at a lower level; on the contrary, if there was no cough, the next mouse would be stimulated with ammonia gas at a higher level; Only animals were not tested, and the opposite response of the previous mouse was counted. The half cough-induced time (EDT50) and the relative value R of the treatment group and the control group were calculated respectively by weighting method.

EDT50=log-1∑rixi/∑ni EDT 50 =log -1 ∑r i x i /∑n i

ni为各刺激时间段试验动物数(不论咳嗽与否),xi为各刺激时间段对数,i为相邻刺激对数之差。 n i is the number of test animals in each stimulation time period (whether coughing or not), x i is the logarithm of each stimulation time period, and i is the difference between adjacent stimulus logarithms.

R=(给药组EDT50/对照组EDT50)×100% R=(EDT 50 of administration group/EDT 50 of control group)×100%

若R>130%,认为药物有镇咳作用;若R>150%,认为药物有明显镇咳作用。 If R>130%, it is considered that the drug has antitussive effect; if R>150%, it is considered that the drug has obvious antitussive effect. the

3.2.2分组和给药 3.2.2 Grouping and administration

昆明种小鼠60只,雌雄各半,随机分为5组,即生理盐水组,对叶百部、直立百部和蔓生百部提取物组,磷酸可待因组。给药途径均为灌胃,给药体积为0.01ml/g。磷酸可待因的给药剂量为0.030g/kg,对叶百部、直立百部和蔓生百部按生药折算的给药剂量为20g/kg,按提取物折算的给药量分别为0.408g/kg、0.200g/kg、0.240g/kg。 Sixty Kunming mice, half male and half male, were randomly divided into 5 groups, that is, the normal saline group, the extracts of Phyllostachys chinensis, Phyllostachys erecta and Phytophthora vines, and the codeine phosphate group. The route of administration is all intragastric administration, and the administration volume is 0.01ml/g. The dosage of codeine phosphate is 0.030g/kg, the dosage converted by crude drug is 20g/kg, and the dosage converted by extract is 0.408g respectively /kg, 0.200g/kg, 0.240g/kg. the

3.1.3镇咳作用的试验结果 3.1.3 Test results of antitussive effect

对三种百部提取物的进行镇咳实验,结果见表12。 Antitussive experiments were carried out on three kinds of Bubu Bu extracts, and the results are shown in Table 12. the

表12三种百部提取物的镇咳实验比较 Table 12 Comparison of antitussive experiments of three kinds of Bubu extracts

  组别group   剂量(g/kg)Dose (g/kg)   EDT50(s)EDT 50 (s)   RR   生理盐水normal saline   //   15.515.5   100%100%   可待因codeine   0.0300.030   33.933.9   219%219%   对叶百部提取物Herba Leaf Extract   0.4080.408   28.228.2   182%182%   直立百部提取物Centipeda erectus extract   0.2000.200   25.125.1   162%162%   蔓生百部提取物vine root extract   0.2400.240   29.129.1   188%188%

由表12可知,三种百部提取物都有明显的的镇咳作用。 It can be seen from Table 12 that the three kinds of Bubu extracts all have obvious antitussive effect. the

对三种百部提取物的生物碱有效部位的镇咳试验,结果见表13。 See Table 13 for the results of the antitussive test on the effective parts of the alkaloids of the three kinds of Bubu Bu extracts. the

表13三种百部提取物的生物碱部分和非生物碱部分镇咳实验结果 Table 13 Antitussive test results of the alkaloid part and non-alkaloid part of the three kinds of Bacillus chinensis extracts

Figure G06127717020060630D000121
Figure G06127717020060630D000121

3.3祛痰作用研究 3.3 Research on expectorant effect

方法:小鼠给药前禁食不禁水8~12小时,灌胃给药后0.5h,分别由腹腔注射0.5%酚红溶液0.5mL,0.5h后颈椎脱臼法处死小鼠,背位固定,分离气管,于喉头下将磨平的7号针头插入气管内约0.3cm,用丝线结扎固定后,用1ml注射器吸取5%碳酸氢钠溶液0.5mL,通过针头来回灌洗呼吸道3次,冲洗液置于试管中,再重复2次,合并冲洗液,高速离心(9500r·min-1)5min,小心取上清液于紫外可见分光光度计波长560nm处测定吸收度值,带入酚红的标准曲线,求算排泌酚红的量。结果见表14。 Methods: The mice were fasted for 8 to 12 hours before administration, and 0.5 hours after intragastric administration, 0.5 mL of 0.5% phenol red solution was injected into the intraperitoneal cavity, and the mice were killed by cervical dislocation after 0.5 hours, and the dorsal position was fixed. Separate the trachea, insert a smoothed No. 7 needle into the trachea about 0.3cm below the throat, ligature and fix it with silk thread, draw 0.5mL of 5% sodium bicarbonate solution with a 1ml syringe, and lavage the respiratory tract back and forth for 3 times through the needle. Put it in a test tube and repeat it 2 more times. Combine the washing liquid and centrifuge at a high speed (9500r·min -1 ) for 5min. Carefully take the supernatant and measure the absorbance value at a wavelength of 560nm with a UV-visible spectrophotometer. Curve to calculate the amount of excreted phenol red. The results are shown in Table 14.

表14各组祛痰效果比较(n=10,X±S) Table 14 Comparison of expectorant effects in each group (n=10, X±S) 

  组别group   剂量(mg/g)Dose (mg/g)   酚红含量(ug/ml)Phenol red content (ug/ml)   生理盐水normal saline   //   1.667±0.16651.667±0.1665   氯化铵ammonium chloride   0.030.03   3.152±0.4359  #3.152±0.4359 #   对叶百部To Ye Baibu   0.2040.204   3.147±0.8160  #3.147±0.8160 #   直立百部upright hundred   0.200.20   2.136±0.4008  # *2.136±0.4008 # *   蔓生百部vines   0.240.24   2.185±0.4999  # *2.185±0.4999 # *

#与生理盐水比较有显著性差异;*与氯化铵比较有显著性差异。 #Compared with normal saline, there is a significant difference; *Compared with ammonium chloride, there is a significant difference. the

由表可知,对叶百部、直立百部和蔓生百部总生物碱的祛痰作用与生理盐水相比较都有非常显著性差异,氯化铵和对叶百部总生物碱相比无显著性差异,但和直立百部、蔓生百部总生物碱相比有显著性差异。 It can be seen from the table that the expectorant effect on the total alkaloids of C. chinensis, C. erectus and C. vines is significantly different from that of normal saline, and there is no significant difference between ammonium chloride and the total alkaloids of C. However, there were significant differences compared with the total alkaloids of Litonia erectus and Litonia vines. the

3.4液体培养法检测百部生物碱有效部位抗结核菌生长效果 3.4 Liquid culture method to detect the anti-tuberculosis growth effect of the effective parts of alkaloids

方法:菌株H37Rv经过碾磨后在Middlebrook7H9培养基中(含改良的OADC营养添加剂)配制成1mg/ml浓度,在1.9ml含不同浓度药物的7H9培养基中各加入0.1ml菌液;实验设空白对照组,溶剂对照组,阳性对照药为利福平(终浓度1ug/ml),每组设2个平行管;混匀反应管,37℃培养15天后,检测药物对结核菌生长的作用。对照组菌量达++以上的视为有效实验。结果见表15。 Method: After milling, strain H37Rv was prepared in Middlebrook 7H9 medium (containing improved OADC nutritional supplement) to a concentration of 1mg/ml, and 0.1ml of bacterial liquid was added to 1.9ml of 7H9 medium containing different concentrations of drugs; the experiment was set as a blank Control group, solvent control group, positive control drug is rifampicin (final concentration 1ug/ml), every group is set up 2 parallel tubes; Mix the reaction tube, after cultivating for 15 days at 37 ℃, detect the effect of drug on the growth of Mycobacterium tuberculosis. The control group with a bacterial count of ++ or more was considered an effective experiment. The results are shown in Table 15. the

表15液体培养法检测药物抗结核菌生长药效结果表 Table 15 liquid culture method to detect drug anti-tuberculosis growth efficacy result table

经液体培养法检测均发现蔓生百部生物碱样品在250ug/ml时能抗结核菌生长,表明蔓生百部生物碱在体外有抗结核菌生长的作用,但作用弱于利福平。 It was found by the liquid culture method that the alkaloids of Libidota alkaloids could resist the growth of Mycobacterium tuberculosis at 250ug/ml, which indicated that the alkaloids of Libidoceae alkaloids had the effect of anti-Mycobacterium tuberculosis growth in vitro, but the effect was weaker than that of rifampicin. the

3.5百部生物碱有效部位杀虫试验 3.5 Insecticidal test of effective parts of Baibu alkaloids

按照GB13917. 2-92进行(即密闭圆筒法);将供试昆虫(淡水库蚊20,羽化后第2~3d未吸血雌成蚊;家蝇30只,羽化后第4~5d成虫,雌雄各半)麻醉后放入圆筒内,待试虫恢复正常后,按0.5g/筒和1.0g/筒的剂量将药液喷入圆筒内,并立即用胶塞,将圆孔塞住,1min后抽出挡板,并及时记录每段时间所击倒的试虫数,20min后,将圆筒内全部试虫移至清洁笼中用5%的葡萄糖水棉球正常饲养,并观察24h试虫死亡数,计算KT50和死亡率,试验重复3次,同时设空白对照组。结果见表16。 Carry out according to GB13917. 2-92 (i.e. closed cylinder method); test insects (20 freshwater Culex mosquitoes, non-blood-sucking female adult mosquitoes on the 2nd to 3d after eclosion; 30 houseflies, adults on the 4th to 5th day after eclosion, half male and half male) were anesthetized and placed in the cylinder. After the test insects returned to normal, the liquid was sprayed into the cylinder at the dose of 0.5g/tube and 1.0g/tube, and the round hole was plugged with a rubber stopper immediately. Stop, take out the baffle after 1 minute, and record the number of test insects knocked down in each period of time in time. After 20 minutes, move all the test insects in the cylinder to a clean cage and raise them normally with 5% glucose water cotton balls, and observe The number of dead insects in 24 hours was calculated to calculate KT50 and mortality. The experiment was repeated 3 times, and a blank control group was set at the same time. The results are shown in Table 16. the

表16百部生物碱杀虫试验 Table 16 Baibu alkaloid insecticidal test

由表可知,百部生物碱对淡水库蚊和家蝇均有杀灭作用。 It can be seen from the table that the alkaloids of Phetopus have killing effects on freshwater Culex mosquitoes and houseflies. the

3.6不同提取物在大、小鼠体内的药代动力学参数计算与比较 3.6 Calculation and comparison of pharmacokinetic parameters of different extracts in rats and mice

蔓生百部生物碱有效部位和原百部碱在大、小鼠体内的药代动力学参数比较,结果见表17。 Table 17 shows the comparison of pharmacokinetic parameters between the active parts of the alkaloids of the vine and the protobarkine in rats and mice. the

表17大、小鼠体内的药代动力学参数比较 Table 17 Comparison of pharmacokinetic parameters in mice and mice

Figure G06127717020060630D000142
Figure G06127717020060630D000142

由表4.22可知,无论是大鼠还是小鼠,灌胃给药百部生物碱有效部位生物利用度高于原百部碱单体。提示百部生物碱有效部位中可能含有促进原百部碱吸收的物质或含有与原百部碱类似结构的成分,在吸收时能饱和代谢原百部碱的酶,减少原百部碱的首过效应。 It can be seen from Table 4.22 that whether it is rats or mice, the bioavailability of the effective part of the alkaloids administered by intragastric administration is higher than that of the original monobasine monomer. It is suggested that the effective parts of crotonine alkaloids may contain substances that promote the absorption of crocetin or components with a structure similar to crocetin, which can saturate the enzymes that metabolize crocetin during absorption and reduce the first over effect. the

Claims (10)

1.一种百部生物碱有效部位,其特征在于:所述百部生物碱有效部位是通过下述方法提取的,包括两步:1. an effective part of alkaloids of bacifera, characterized in that: the effective parts of alkaloids of bacifera are extracted by the following method, comprising two steps: (1)、采用乙醇或酸水提取:将百部药材粉碎成粗粉,并用70%-90%乙醇或者用pH值为1-5的酸水提取;(1), using ethanol or acid water extraction: crush the medicinal material of Herba Cinnamomi into coarse powder, and extract with 70%-90% ethanol or acid water with a pH value of 1-5; (2)、阳离子交换树脂纯化:将(1)步骤提取的上清液通过阳性交换树脂,洗脱除去水溶性杂质,以氨水和乙醇溶液洗脱,至碘化铋钾反应成阴性,停止洗脱,洗脱液减压回收至干,粉碎,得百部总生物碱提取物,百部生物碱有效部位含量在50%以上。(2), cation exchange resin purification: pass the supernatant extracted in step (1) through a positive exchange resin, elute to remove water-soluble impurities, elute with ammonia water and ethanol solution, until bismuth potassium iodide reacts negatively, stop washing The eluate is recovered to dryness under reduced pressure, and crushed to obtain the total alkaloid extract of the plant, the content of the active parts of the plant being more than 50%. 2.根据权利要求1所述的百部生物碱有效部位,其特征在于:所述(1)步骤中采用70%-90%乙醇采用加热回流或渗漉的方法来进行提取。2. The active part of the plant alkaloid according to claim 1, characterized in that: in the step (1), 70%-90% ethanol is used for extraction by heating to reflux or percolation. 3.根据权利要求2所述的百部生物碱有效部位,其特征在于:所述(1)步骤中采用的是90%乙醇提取,提取3次,每次1小时。3. The effective part of the alkaloids according to claim 2, characterized in that: 90% ethanol extraction is adopted in the (1) step, and the extraction is 3 times, 1 hour each time. 4.根据权利要求1所述的百部生物碱有效部位,其特征在于:所述(2)步骤的氨水和乙醇洗脱液体积比为:4∶1~1∶4。4. The active part of the alkaloids of A. mellifera according to claim 1, characterized in that: the volume ratio of ammonia water and ethanol eluent in the step (2) is: 4:1-1:4. 5.根据权利要求1所述的百部生物碱有效部位,其特征在于:所述(2)步骤所用阳离子交换树脂为强酸性或弱酸性阳离子交换树脂。5 . The active part of the alkaloids according to claim 1 , characterized in that: the cation exchange resin used in the (2) step is a strongly acidic or weakly acidic cation exchange resin. 6 . 6.根据权利要求5所述的百部生物碱有效部位,其特征在于:阳离子交换树脂为HZ004或JK008。6 . The active part of the alkaloids according to claim 5 , characterized in that: the cation exchange resin is HZ004 or JK008. 7.权利要求1-6所述的百部生物碱有效部位在制备治疗螨虫、脚癣、体癣、酒渣鼻、皮炎、湿疹、荨麻疹、体虱、头虱或滴虫性阴道炎的药物或化妆品中的应用,所述药物剂型为软膏剂、凝胶剂、洗剂或栓剂。7. the effective parts of the alkaloids described in claims 1-6 are used in the preparation of medicines for the treatment of mites, athlete's foot, tinea corporis, rosacea, dermatitis, eczema, urticaria, body lice, head lice or trichomonal vaginitis Or the application in cosmetics, the pharmaceutical dosage form is ointment, gel, lotion or suppository. 8.权利要求1-6所述的百部生物碱有效部位在制备治疗咳嗽、支气管炎、肺炎或肺结核的药物中的应用,所述药物剂型为片剂、软胶囊剂、微囊剂、颗粒剂、丸剂、散剂、缓释制剂、控释制剂、胃肠定位制剂、口服液体制剂、注射液、粉针及其它药剂学上可接受的剂型。8. the application of the effective part of the alkaloids described in claim 1-6 in the preparation of the medicine for the treatment of cough, bronchitis, pneumonia or tuberculosis, the dosage form of the medicine is tablet, soft capsule, microcapsule, granule Drugs, pills, powders, sustained-release preparations, controlled-release preparations, gastrointestinal targeted preparations, oral liquid preparations, injections, powder injections and other pharmaceutically acceptable dosage forms. 9.权利要求1-6所述的百部生物碱有效部位在制备治疗蛲虫病、蛔虫病或动物寄生虫疾病的药物中的应用。9. The application of the effective part of the alkaloids described in claims 1-6 in the preparation of medicines for treating pinworms, ascariasis or animal parasitic diseases. 10.权利要求1-6所述的百部生物碱有效部位在制备防治果树、蔬菜、花卉或玉米植物病害虫害的药物中的应用。10. The application of the effective parts of the alkaloids of the plant according to claims 1-6 in the preparation of medicines for the prevention and treatment of fruit trees, vegetables, flowers or corn plant diseases and insect pests.
CN2006100277170A 2006-06-13 2006-06-13 Effective Parts of Alkaloids and Their Applications Expired - Fee Related CN101088553B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006100277170A CN101088553B (en) 2006-06-13 2006-06-13 Effective Parts of Alkaloids and Their Applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100277170A CN101088553B (en) 2006-06-13 2006-06-13 Effective Parts of Alkaloids and Their Applications

Publications (2)

Publication Number Publication Date
CN101088553A CN101088553A (en) 2007-12-19
CN101088553B true CN101088553B (en) 2011-02-09

Family

ID=38942154

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006100277170A Expired - Fee Related CN101088553B (en) 2006-06-13 2006-06-13 Effective Parts of Alkaloids and Their Applications

Country Status (1)

Country Link
CN (1) CN101088553B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103449931B (en) * 2013-09-12 2015-01-28 新疆久业富硒农业科技开发有限公司 Disease prevention and frost resistance fruit selenium-enriching nutritional agent for fruit trees and preparation method of disease prevention and frost resistance fruit selenium-enriching nutritional agent
CN104257661B (en) * 2014-07-30 2017-02-22 中国药科大学 Application of azaazulene alkaloids topreparing medicine for preventing or treating pulmonary fibrosis
CN105494484A (en) * 2015-07-10 2016-04-20 罗友祥 Technology for preparing crop bactericide by using traditional Chinese medicines
CN105997637A (en) * 2016-06-08 2016-10-12 马殿伟 Traditional Chinese medicine composition containing Radix Stemonae and used for acarid-eliminating cosmetics
CN110731352A (en) * 2019-10-30 2020-01-31 凉山德农生物能源股份有限公司 Jatropha curcas extract insecticidal sustained-release gel and preparation method thereof
CN111529455B (en) * 2020-06-18 2022-02-25 广州鹰远生物科技有限公司 Multi-effect washing and protecting composition and application thereof
CN111789786B (en) * 2020-08-13 2022-11-11 广州极男化妆品有限公司 Mite-killing plant composition and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1453279A (en) * 2002-04-24 2003-11-05 香港中文大学 Plant extracts and alkaloids with antitussive activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1453279A (en) * 2002-04-24 2003-11-05 香港中文大学 Plant extracts and alkaloids with antitussive activity

Also Published As

Publication number Publication date
CN101088553A (en) 2007-12-19

Similar Documents

Publication Publication Date Title
CN101088553B (en) Effective Parts of Alkaloids and Their Applications
CN101664446A (en) Relinging extractum and preparation method and application
CN101869656A (en) A kind of traditional Chinese medicine preparation for treating cough and asthma and preparation method thereof
CN102085257B (en) Preparation method of cassia twig and poria cocos pellet
CN102048785B (en) Application of Eupatorium adenophorum in the preparation of veterinary medicine or feed additive
KR20040032920A (en) Fermentation product of cyptoporus volvatus and its preparation method and use
CN102805767A (en) Heat stranguria removal granule raw material polygonum capitatum extract with anti-gonococcus effect
CN101474383A (en) Preparation method of garlic total saponin as well as products produced thereby and application
CN108785374A (en) Faint scent cassia bark skin bacteriostatic gel and preparation method thereof
CN1939417B (en) Medicinal composition of douricine, tinosporae or its extract
CN1939414B (en) Medicinal composition with antibacterial and anti-inflammation functions
CN101554405A (en) Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof
CN103191282A (en) Traditional Chinese medicinal composition for treating fever in children as well as preparation method and application thereof
CN102293948A (en) Preparation for treating children dyspepsia endogenous heat, and preparation method and detection method of preparation
CN102988552A (en) Traditional Chinese medicine compound radix pulsatillae particle for treating chicken colibacillosis and preparation method and application thereof
CN102775455A (en) Dihydromyricetin medicine treating acute and chronic bronchitis and its preparation method
CN108219024B (en) Calophyllum inophyllum flower polysaccharide, extraction method thereof and application thereof in preparing medicine for treating functional constipation
CN102441064A (en) Traditional Chinese medicine composition for treating diabetes and preparation thereof
CN102336795A (en) Eucommia ulmoides Oliv active monomer compound and preparation method thereof as well as medicament composition and application thereof
CN102258620B (en) Chinese medicinal injection for treating mixed infection of swine streptococcus and swine fever and preparation method thereof
CN102716275B (en) Detection method of anti-anxiety pharmaceutical composition
CN1709299A (en) Chinese medicine formulation for treating asthma and its preparing method
CN101322735A (en) Optimizing method for attenuation processing of Tripterygium wilfordii and related formulation
CN101721437B (en) Preparation method of pharmaceutical composition for treating chronic pharyngitis
CN1939412B (en) Medicinal composition with dauricine and houttuynin sodium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110209

Termination date: 20180613